Lung Cancer Clinical Trials in Osaka, Hirakata
2 recruitingOsaka, Hirakata, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Non-small Cell Lung Cancer
Boehringer Ingelheim400 enrolled192 locationsNCT07195695
Recruiting
Phase 1
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Liver CancerColorectal, CancerPancreatic Cancer+3 more
Boehringer Ingelheim97 enrolled7 locationsNCT06091930